Marinus Pharmaceuticals Inc (MRNS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5 RADNOR CORPORATE CENTER SUITE 500 RADNOR, PA 19087

Marinus Pharmaceuticals, Inc. manufactures medical products. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post traumatic stress, and fragile-x syndrome.

Data as of 2020-08-01
Market Cap205.303 Million Shares Outstanding122.204 Million Avg 30-day Volume1.628 Million
P/E Ratio Dividend Yield EPS-1.07
Price/Sales Price cash flow ratio Price free cash flow ratio-4.9
Book Value0.35 Price to Tangible Book4.85 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.080553
BETA2.02239 52-week High/Low3.5 / 1.01 Stddev0.306579

Are you looking for this stock instead?

View SEC Filings from MRNS instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 1 (0.07%)
13F Filers holding this stock: 76 26 (1.7%)
Aggregate 13F shares on 03/31/2020: 64.513 Million 33.092 Million
Aggregate 13F shares on 12/31/2019: 56.081 Million 30.03 Million
Percent change: 15.03% 10.20%
Funds creating new positions: 16 4
Funds Adding to an existing position: 30 10
Funds closing out their position: 18 12
Funds reducing their position: 12 3
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MRNS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MRNS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

AUSTIN CHARLES

  • Director
0 2020-07-29 2

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BAIN CAPITAL LIFE SCIENCES FUND, L.P.

BCIP LIFE SCIENCES ASSOCIATES, LP

KOPPEL ADAM

BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

SCHWARTZ JEFFREY LAWRENCE

  • 10% Owner
3,241,628 2020-07-28 0

DOUGHERTY MICHAEL R

  • Director
28,408 2020-07-01 1

MEHRA ANAND

  • Director
0 2020-06-30 0

FARFEL GAIL M EVP/CHIEF DEVELOPMENT OFFICER

  • Officer
11,179 2020-06-25 0

BLOCH STEPHEN M

  • Director
0 2020-06-22 0

FISCHER SETH H. Z.

  • Director
32,500 2020-06-18 1

MANNING MARTHA E VP, GEN. COUNSEL & CORP. SEC.

  • Officer
0 2020-06-15 2

BRAUNSTEIN SCOTT

  • Director
0 2020-06-09 2

SHEPARD JAY

  • Director
11,073 2020-05-28 0

VITULLO NICOLE

  • Director
19,392 2020-05-28 1

SMITH EDWARD F

  • Director
0 2020-04-15 3

MAYLEBEN TIMOTHY M PRESIDENT & CEO

  • Officer
  • Director
111,998 2020-03-11 1

CARRAZANA ENRIQUE J.

  • Director
0 2020-01-08 1

HULIHAN JOSEPH CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-08 2

EZICKSON ELAN

  • Director
71,887 2019-12-31 2

LORIANNE MASUOKA K. CHIEF MEDICAL OFFICER

  • Officer
0 2019-08-21 1

CASHMAN CHRISTOPHER MICHAEL CEO

  • Officer
  • Director
271,423 2019-03-18 0

CANAAN VII LP

CANAAN PARTNERS VII LLC

  • 10% Owner
No longer subject to file 2018-10-25 0

MEHRA ANAND

SOFINNOVA VENTURE PARTNERS VI L P

SOFINNOVA VENTURE PARTNERS VI GMBH & CO. KG

SOFINNOVA VENTURE AFFILIATES VI LP

SOFINNOVA MANAGEMENT VI, L.L.C.

BUATOIS ERIC

HEALY JAMES

AZAN ALAIN

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2016-10-20 0

PATRONEVA ALBENA CHIEF MEDICAL OFFICER

  • Officer
0 2016-08-03 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • 10% Owner
63,200 2015-06-24 0

DOMAIN PARTNERS VI, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

  • Director
  • 10% Owner
2,245,902 2015-05-11 0

DP VI ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

  • Director
  • 10% Owner
3,519 2015-05-11 0

GOPKA ANTON

  • Director
0 2015-01-01 0

SHAH NIMESH

  • 10% Owner
38,094 2015-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

AUSTIN CHARLES - Director

2020-07-29 A 100,000 a 100,000 0.00 direct

MANNING MARTHA E - Officer VP, GEN. COUNSEL & CORP. SEC.

2020-06-15 A 300,000 a 300,000 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments